Login
Subscribe
Why Some HPV Infections Carry More Cervical Cancer Risk
Why Some HPV Infections Carry More Cervical Cancer Risk
Where and how human papillomavirus integrates itself into the human genome steers the infection’s clinical outcomes, finds a large, multifaceted study.
Where and how human papillomavirus integrates itself into the human genome steers the infection’s clinical outcomes, finds a large, multifaceted study.
virology
Transmissible Tumors, 1909
Katherine Irving | Jan 2, 2023 | 2 min read
Pathologist Peyton Rous made a groundbreaking discovery in the early 20th century, but his work wasn’t widely recognized until more than 40 years later.
Monir Moniruzzaman Studies the Secrets of Giant Viruses
James M. Gaines | Jan 2, 2023 | 4 min read
The University of Miami researcher studies how a mysterious group of supersized viruses infects and influences the evolution of their hosts.
COVID-19: Lessons Learned
The Scientist’s Creative Services Team | 2 min read
An expert panel will discuss what researchers have learned from the COVID-19 pandemic and what lessons remain for the future.
What Happens When You Catch More than One Virus?
Alejandra Manjarrez, PhD | Dec 7, 2022 | 8 min read
The “tripledemic” shines a spotlight on viral interference, in which one infection can block another.
Recently Discovered Virus Family Infects a Human Oral Amoeba
Alejandra Manjarrez, PhD | Dec 1, 2022 | 3 min read
Redondoviruses, which have been associated with cases of periodontitis and other diseases, turn out to live inside the amoeba Entamoeba gingivalis.
The Scientist Speaks - To Conserve and Protect: The Quest for Universal Vaccines
Niki Spahich, PhD | 1 min read
Patrick Wilson discusses the challenges in designing universal vaccines and his work developing one for influenza.
Scientists ID Heart-Damaging SARS-CoV-2 Protein
Grace van Deelen | Nov 22, 2022 | 3 min read
In flies and mice, a viral protein increases the rate of energy use by heart cells. But it’s not yet clear if the finding applies to humans.
US Agency to Look into Project on Modified Coronavirus
Catherine Offord | Oct 18, 2022 | 3 min read
The National Institute of Allergy and Infectious Diseases was not aware that the work involved a chimeric strain of SARS-CoV-2, STAT reports.
Wastewater’s Hidden Value for Monitoring Public Health
The Scientist’s Creative Services Team and Bio-Rad Laboratories | 1 min read
Learn about wastewater-based epidemiology—from its conception to its present state and into its future.
![several blue office chairs sit empty in a carpeted room, with a paper sign saying "Vaccination centre welcome" pasted on the white wall above. ](https://cdn.the-scientist.com/assets/articleNo/70641/aImg/48209/empty-chair-article-image-t.jpg "several blue office chairs sit empty in a carpeted room, with a paper sign saying "Vaccination centre welcome" pasted on the white wall above. ")
Is a Winter COVID-19 Case Surge Coming?
Katherine Irving | Oct 17, 2022 | 3 min read
Low booster rates and immune-evading SARS-CoV-2 variants could spell bad news, experts say.
Unprecedented Avian Flu Epidemic Could Presage Year-Round Outbreaks
Christie Wilcox, PhD | Oct 4, 2022 | 2 min read
Nearly 50 million birds have been culled amid efforts to mitigate the spread of the virus, which continues to ravage the Northern Hemisphere.
The Genetics Behind Immune Response Variability
The Scientist’s Creative Services Team | 1 min read
Researchers seek genomic clues to understand differences in the immune response to infection.
Experts Mixed on Risk of “Centaurus” Omicron Subvariant
Dan Robitzski | Aug 15, 2022 | 3 min read
BA.2.75 is spreading rampantly in India and has so far reached at least 20 other countries, but it doesn’t seem to be outcompeting other Omicron SARS-CoV-2 subvariants.
What Is This New Langya Virus? Do We Need to Be Worried?
Allen Cheng, The Conversation | Aug 11, 2022 | 3 min read
Here’s what we know so far about a new virus detected in eastern China.
Characterizing Proteolysis During SARS-CoV-2 Infection
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | 1 min read
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
How the Omicron Subvariant BA.5 Became a Master of Disguise—and What It Means for the Current COVID-19 Surge
Suresh V. Kuchipudi, The Conversation | Jul 26, 2022 | 4 min read
Several mechanisms contribute to the increased transmissibility of this SARS-CoV-2 variant.
Opinion: Destroy All Samples of the Smallpox Virus
Gigi Gronvall and Tara Kirk Sell | Jun 1, 2022 | 3 min read
With a global alarm ringing because of an unprecedented outbreak of monkeypox, we should also consider a different but closely related viral threat.
Form Determines Function: Insights from Structural Biology
The Scientist’s Creative Services Team | 1 min read
Researchers use diverse tools to analyze protein structures.
New Mechanism for Virus-Triggered Autoimmunity Uncovered
Sophie Fessl, PhD | Mar 11, 2022 | 4 min read
Roseolovirus infection disrupts how the body trains immune cells not to attack it, a mouse study shows.